Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100.
Thorpy MJ, Dauvilliers Y. Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Med. 2015;16:9–18.
Rosenberg R, Kim AY. The AWAKEN survey: knowledge of narcolepsy among physicians and the general population. Postgrad Med. 2014;126:78–86.
Bassetti CLA, Adamantidis A, Burdakov D, et al. Narcolepsy-clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15:519–39.
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.
Morse AM. Narcolepsy in children and adults: a guide to improved recognition, diagnosis and management. Med Sci (Basel). 2019;7:106.
Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep. 2002;25:27–35.
Thorpy M, Morse AM. Reducing the clinical and socioeconomic burden of narcolepsy by earlier diagnosis and effective treatment. Sleep Med Clin. 2017;12:61–71.
Maski K, Steinhart E, Williams D, et al. Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy. J Clin Sleep Med. 2017;13:419–25.
Article PubMed PubMed Central Google Scholar
Ortiz L, Morse AM, Krahn L, et al. A Survey of People Living with Narcolepsy in the USA: Path to Diagnosis, Quality of Life, and Treatment Landscape from the Patient's Perspective. CNS Drugs. 2025;
Baldini V, Venezia N, Iriti A, et al. Eating disorders in narcolepsy type 1: evidence from a cross-sectional Italian study. J Sleep Res. 2024;33: e14150.
Fortuyn HA, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep. 2008;31:335–41.
Article PubMed PubMed Central Google Scholar
Merino D, Gerard AO, Van Obberghen EK, et al. Medications as a trigger of sleep-related eating disorder: a disproportionality analysis. J Clin Med. 2022;11:3890.
Wallace DM, Maze T, Shafazand S. Sodium oxybate-induced sleep driving and sleep-related eating disorder. J Clin Sleep Med. 2011;7:310–1.
Article PubMed PubMed Central Google Scholar
Feketeová E, Dragašek J, Klobučníková K, et al. Psychotic episode and schizophrenia in Slovakian Narcolepsy Database. Brain Sci. 2022;13:43.
Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27:1361–7.
Article PubMed PubMed Central Google Scholar
Krahn LE, Zee PC, Thorpy MJ. Current understanding of narcolepsy 1 and its comorbidities: what clinicians need to know. Adv Ther. 2022;39:221–43.
Swift JK, Callahan JL, Cooper M, Parkin SR. The impact of accommodating client preference in psychotherapy: a meta-analysis. J Clin Psychol. 2018;74:1924–37.
Chewning B, Bylund CL, Shah B, et al. Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2012;86:9–18.
Thom DH, Campbell B. Patient-physician trust: an exploratory study. J Fam Pract. 1997;44:169–76.
American Academy of Sleep Medicine. International classification of sleep disorders—third edition text revision, summary of diagnostic criteria changes. 3rd ed. Darien: American Academy of Sleep Medicine; 2023.
Barateau L, Dauvilliers Y. Recent advances in treatment for narcolepsy. Ther Adv Neurol Disord. 2019;12:1756286419875622.
Article CAS PubMed PubMed Central Google Scholar
Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369:499–511.
Bassetti CLA, Kallweit U, Vignatelli L, et al. European guideline and expert statements on the management of narcolepsy in adults and children. Eur J Neurol. 2021;28:2815–30.
Barateau L, Lopez R, Dauvilliers Y. Treatment options for narcolepsy. CNS Drugs. 2016;30:369–79.
Article CAS PubMed Google Scholar
Bogan RK, Roth T, Schwartz J, Miloslavsky M. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy. J Clin Sleep Med. 2015;11:427–32.
Article PubMed PubMed Central Google Scholar
Watson NF, Davis CW, Zarycranski D, et al. Time to onset of response to pitolisant for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy: an analysis of randomized, placebo-controlled trials. CNS Drugs. 2021;35:1303–15.
Article CAS PubMed PubMed Central Google Scholar
Levy AG, Scherer AM, Zikmund-Fisher BJ, et al. Prevalence of and factors associated with patient nondisclosure of medically relevant information to clinicians. JAMA Netw Open. 2018;1: e185293.
Article PubMed PubMed Central Google Scholar
Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with narcolepsy: current management strategies, future prospects, and overlooked real-life concerns. Nat Sci Sleep. 2020;12:453–66.
Article PubMed PubMed Central Google Scholar
Shay LA, Lafata JE. Understanding patient perceptions of shared decision making. Patient Educ Couns. 2014;96:295–301.
Article PubMed PubMed Central Google Scholar
van Uden-Kraan CF, Drossaert CH, Taal E, et al. Participation in online patient support groups endorses patients’ empowerment. Patient Educ Couns. 2009;74:61–9.
Narcolepsy Network. About us. https://narcolepsynetwork.org/about-us/. Accessed 10 June 2024.
Wake Up Narcolepsy. About wake up narcolepsy. https://www.wakeupnarcolepsy.org/about-wun/. Accessed 10 June 2024.
Project Sleep. Our mission. https://project-sleep.com/about-us/. Accessed 10 June 2024.
Varallo G, Franceschini C, Rapelli G, et al. Navigating narcolepsy: exploring coping strategies and their association with quality of life in patients with narcolepsy type 1. Sci Rep. 2024;14:11837.
Article CAS PubMed PubMed Central Google Scholar
Schokman A, Cheung J, Milton A, et al. Making sense of narcolepsy: a qualitative exploration of how persons with narcolepsy perceive symptoms and their illness experience. Sleep Med. 2024;116:62–70.
Xyrem International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med. 2005;1:391–7.
U.S. Xyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep. 2002;25:42–9.
U.S. Xyrem Multicenter Study Group. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep. 2003;26:31–5.
Bogan RK, Thorpy MJ, Dauvilliers Y, et al. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy. Sleep. 2021;44:zsaa206.
Roth T, Dauvilliers Y, Thorpy MJ, et al. Effect of FT218, a once-nightly sodium oxybate formulation, on disrupted nighttime sleep in patients with narcolepsy: results from the randomized phase III REST-ON trial. CNS Drugs. 2022;36:377–87.
Comments (0)